Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew N. Schiff currently holds 22,100 shares of Aclaris Therapeutics, Inc. (ACRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew N. Schiff has been a net seller of ACRS stock. They have purchased $23.2M and sold $291.8M worth of shares.
Andrew N. Schiff's most recent insider trade was on Jun 12, 2024, when they sold 22,100 shares at $0.00 per share.
Andrew N. Schiff serves as Executive at Aclaris Therapeutics, Inc. (ACRS). They have executed 53 insider transactions totaling $314.9M over their tenure at the company.
Andrew N. Schiff holds the position of Executive at Aclaris Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Andrew N. Schiff has shown a selling trading pattern, with $23.2M in total purchases and $291.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew N. Schiff was on Jul 10, 2018, when they sold $251.2M worth of LOXO shares. This transaction involved 1,400,000 shares at $179.43 per share.
Andrew N. Schiff currently owns 22,100 shares of Aclaris Therapeutics, Inc. (ACRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew N. Schiff's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew N. Schiff has 53 Form 4 filings on record as an insider at Aclaris Therapeutics, Inc..
Set alerts for Andrew N. Schiff and 40,000+ other insiders.